The Impact of Salmon Protein Hydrolysate (SPH / ProGo®) Supplementation on Hematologic and Metabolic Health

Clinical trial NCT07616752 · COMPLETED

Trial details

NCT number: NCT07616752
Sponsor: Hofseth Biocare ASA
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Overweight (BMI > 25)Weight Loss

Start date: 2019-07-19
Primary completion: 2019-11-03
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.